ASCO GI 2021 | ASCO GI: IO and interventional oncology

Thomas Helmberger, MD, PhD, Muenchen Klinik Bogenhausen, München, Germany, discusses the latest updates presented at this year’s American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, including exciting progress in immuno-oncology (IO), as well as interventional oncology approaches. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).